logo

For the Inventor, By the Inventor

Tübingen, Germany

Hans Georg Rammensee

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents. Top assignees: Immatics Biotechnologies Gmbh, Ludwig Institute for Cancer Research Limited. Active years: 2003-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Georg Rammensee. Retrieved from https://idiyas.com/inventor/hans-georg-rammensee-xxeft38x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 66.7


Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 132(Granted Patents)


Location History:

  • Auf der Morgenstelle, DE (2007)
  • Tubingen-Unterjessingen, DE (2009)
  • Tubingen, DE (2003 - 2010)
  • Tübingen, DE (2008 - 2013)
  • Tuebingen, DE (2015 - 2024)

Company Filing History:

goldMedal10 out of 728 
 
Immatics Biotechnologies Gmbh
 patents
silverMedal2 out of 530 
 
Ludwig Institute for Cancer Research Limited
 patents

Years Active: 2003-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 11957729 - Powerful MHC-class II peptides derived from survivin (2024-04-16),
2. 9783849 - Method for identifying immunoreactive peptides (2017-10-10),
3. 9023804 - HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof (2015-05-05),
4. 9023802 - HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof (2015-05-05),
5. 8536304 - Tumour-associated peptides that bind to MHC molecules (2013-09-17),
6. 8399613 - Tumour-associated peptides that bind to MHC molecules (2013-03-19),
7. 7763711 - Tumour-associated peptides binding to MHC-molecules (2010-07-27),
8. 7666984 - Tumour-associated peptides binding to MHC-molecules (2010-02-23),
9. 7528224 - Peptide for triggering an immune reaction against tumor cells (2009-05-05),
10. 7396904 - Tumor-associated peptides binding to MHC-molecules (2008-07-08),
11. 7270819 - Isolated nucleic acid molecules encoding isolated peptides which correspond to contiguous amino acids of an SSX molecule or NY-ESO-1 and uses thereof (2007-09-18),
12. 6548064 - Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules (2003-04-15),

Title: Hans Georg Rammensee - The Innovative Mind from Tuebingen

Introduction: Hans Georg Rammensee is a distinguished inventor hailing from Tuebingen, Germany, known for his groundbreaking contributions to the field of biotechnology and immunology.

Latest Patents: Hans Georg Rammensee holds several patents related to novel methods for enhancing immune responses and developing personalized cancer therapies.

Career Highlights: With a career spanning over three decades, Rammensee has made significant strides in understanding the human immune system and its role in combating diseases. His research has led to the development of innovative immunotherapies that have the potential to revolutionize cancer treatment.

Collaborations: Throughout his career, Rammensee has collaborated with leading scientists, research institutions, and pharmaceutical companies worldwide to further his research and bring his inventions to the forefront of medical innovation.

Conclusion: Hans Georg Rammensee's relentless pursuit of scientific excellence and passion for innovation continue to inspire the next generation of inventors and researchers in the field of biotechnology and immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…